Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Inventory Average: 2011-2025

Historic Inventory Average for China Pharma Holdings (CPHI) over the last 13 years, with Sep 2025 value amounting to $2.7 million.

  • China Pharma Holdings' Inventory Average rose 1.94% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 1.94%. This contributed to the annual value of $3.4 million for FY2024, which is 1.58% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Inventory Average is $2.7 million, which was down 0.47% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, China Pharma Holdings' Inventory Average ranged from a high of $3.8 million in Q3 2023 and a low of $2.7 million during Q3 2024.
  • Over the past 3 years, China Pharma Holdings' median Inventory Average value was $3.2 million (recorded in 2024), while the average stood at $3.2 million.
  • As far as peak fluctuations go, China Pharma Holdings' Inventory Average spiked by 30.75% in 2023, and later crashed by 30.76% in 2024.
  • China Pharma Holdings' Inventory Average (Quarterly) stood at $3.0 million in 2021, then dropped by 3.10% to $2.9 million in 2022, then spiked by 30.75% to $3.8 million in 2023, then slumped by 30.02% to $2.7 million in 2024, then climbed by 1.94% to $2.7 million in 2025.
  • Its Inventory Average stands at $2.7 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.8 million for Q1 2025.